You just read:

Neurocrine Provides Update on FDA Advisory Committee for INGREZZA™ (valbenazine) for the Treatment of Tardive Dyskinesia

News provided by

Neurocrine Biosciences, Inc.

Jan 05, 2017, 16:01 ET